Scienture Holdings, Inc.
SCNX · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.02 | 0.05 | -0.46 |
| FCF Yield | -13.89% | -21.78% | -5.47% | -30.01% |
| EV / EBITDA | -3.11 | -6.45 | -8.90 | -6.85 |
| Quality | ||||
| ROIC | -5.20% | -3.52% | -3.92% | -3.92% |
| Gross Margin | 0.00% | 6.56% | 5.32% | 5.99% |
| Cash Conversion Ratio | 0.89 | 0.30 | 0.96 | 0.43 |
| Growth | ||||
| Revenue 3-Year CAGR | -44.30% | -71.34% | -74.00% | -76.91% |
| Free Cash Flow Growth | 30.92% | -2.04% | 46.35% | -227.91% |
| Safety | ||||
| Net Debt / EBITDA | -0.68 | -0.74 | -0.51 | -0.74 |
| Interest Coverage | -7.89 | -5.32 | -4.15 | -16.09 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 7.73 |
| Cash Conversion Cycle | -18,262.23 | 17,013.11 | 4,049.19 | 3,795.88 |